Bionano Genomics Inc.

NASDAQ: BNGO · Real-Time Price · USD
3.22
0.01 (0.31%)
At close: Aug 15, 2025, 10:09 AM

Bionano Genomics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
30.78M 36.12M 27.8M 17.98M
Cost of Revenue
30.4M 26.55M 21.86M 14.11M
Gross Profit
380K 9.57M 5.95M 3.87M
Operating Income
-103.98M -215.25M -131.7M -77.1M
Interest Income
2.1M 3.31M 1.51M 236K
Pretax Income
-111.98M -232.43M -130.71M -78.15M
Net Income
-112.02M -232.49M -132.6M -72.44M
Selling & General & Admin
51.85M 94.96M 88.6M 58.49M
Research & Development
24.8M 54.03M 49.05M 22.48M
Other Expenses
27.7M 75.82M -223K -59K
Operating Expenses
104.36M 224.81M 137.64M 80.97M
Interest Expense
289K 5.12M 298K 927K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
105.11M 251.36M 159.5M 95.08M
Income Tax Expense
33K 62K 1.88M -5.72M
Shares Outstanding (Basic)
1.9M 580.38K 491.66K 470.53K
Shares Outstanding (Diluted)
1.9M 580.55K 491.66K 470.53K
EPS (Basic)
-3.6K -24.51K -16.51K -9.42K
EPS (Diluted)
-3.6K -24.52K -16.51K -9.42K
EBITDA
-97.47M -213.6M -120.31M -73.86M
EBIT
-111.69M -227.31M -130.41M -77.22M
Depreciation & Amortization
14.23M 13.71M 10.1M 3.97M